Opioid Prescribing Policy

At OC Regenerative & Pain Center, our mission is to provide safe, effective, and innovative pain management with a focus on regenerative and non-opioid treatments. In line with current medical guidelines, patient safety standards, and the philosophy of our practice, we have adopted the following prescribing policy:

Opioid Management Approach

• Our clinic does not initiate or continue high-dose, long-term opioid therapy for chronic non-cancer pain.

• Patients currently maintained on high-dose opioid regimens who are unable or unwilling to taper are encouraged to remain with their current provider or establish care with a clinic specializing in long-term opioid management.

Safe Prescribing Commitment

• We may consider low-dose or short-term opioid therapy only when medically necessary, in accordance with CDC guidelines, California Medical Board standards, and best clinical practices.

• All opioid use will be closely monitored and accompanied by risk-mitigation strategies, including prescription monitoring, informed consent, and functional outcome tracking.

Alternative Care Options

• Our practice specializes in regenerative therapies (PRP, stem cell-based), interventional procedures,and non-opioid medications.

• Patients seeking care at our center will be offered evaluation and treatment within this model of care.

• For those requiring ongoing high-dose opioid therapy, we will provide referrals to appropriate providers to ensure continuity of care and avoid abrupt treatment disruption.

Patient Communication

• We believe in transparency. Patients will be informed at the outset of their evaluation that our clinic is not an opioid-focused practice.

• This policy is applied consistently to all patients to ensure fairness, safety, and compliance with state and federal standards.